Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

FHS
May 14, 2024
7:50 pm

People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England Journal of Medicine.

Dermavant maps out atopic dermatitis filing after positive Phase III data – Pharmaceutical Technology

Share this article Vtama gained FDA approval in 2022 to treat plaque psoriasis and generated $28m for the fiscal year ending 31 March 2023. Credit:

January 12, 2024

Sun Pharmaceutical Industries sees highest filings and grants during August in Q3 2023

Share this article Sun Pharmaceutical Industries has been focused on protecting inventions in United States(US) with 15 publications in Q3 2023 The United States(US) Patent

December 11, 2023

Innovative platform helps explore genetic links to 99 diseases

A new study introduces the Proteome-Wide Association Study Hub, an innovative and powerful tool designed to explore gene-disease connections across ninety-nine common diseases.

November 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.